5.7 The Impact of Specific Mutations in TP53 Gene on the Results of Alemtuzumab Therapy in CLL Patients
Michael Doubek, Martin Trbusek, Jitka Malcikova, Yvona Brychtova, Jana Smardova, Jana Lochmanova, Anna Panovska, Hana Skuhrova Francova, Marek Mraz, Boris Tichy, Ludmila Sebejova, Petr Dobes, Karla PlVolume:
11
Year:
2011
Language:
english
DOI:
10.1016/j.clml.2011.09.161
File:
PDF, 91 KB
english, 2011